Cost effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in patients with CKD in Norway and Sweden

BACKGROUND: Hyperkalaemia is common in patients with chronic kidney disease (CKD) and is associated with a range of adverse outcomes. Historically, options for management of chronic hyperkalaemia in the outpatient setting have been limited. Novel oral potassium binders provide a safe, effective ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kun, Fagerström, Josefine, Chen, Gengshi, Lagunova, Zoya, Furuland, Hans, McEwan, Phil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373488/
https://www.ncbi.nlm.nih.gov/pubmed/35953778
http://dx.doi.org/10.1186/s12882-022-02903-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373488/
https://www.ncbi.nlm.nih.gov/pubmed/35953778
http://dx.doi.org/10.1186/s12882-022-02903-7

Ejemplares similares